Loxapine succinate

Loxapine Succinate is the succinate salt form of loxapine, a tricyclic dibenzoxazepine antipsychotic agent with antiemetic, sedative, anticholinergic, and antiadrenergic actions. Loxapine succinate exerts its actions by blocking the dopamine receptors at postsynaptic receptor sites in the limbic system, cortical system and basal ganglia, thereby reducing the hallucinations and delusions that are associated with schizophrenia. This agent also exerts extrapyramidal side effects. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Loxapac, Cloxazepin and Daxolin. Its PubChem CID is 71399.

CAS No 27833-64-3
Molecular Formula C22H24ClN3O5
Molecular Weight 445.90 g/mol
Synonyms butanedioic acid;8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepine

Frequently Asked Questions